Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 150
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 151
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
LATEST NEWS UPDATES | Nasal vaccine priced at Rs 800 before taxes -GS Mudur

Nasal vaccine priced at Rs 800 before taxes -GS Mudur

Share this article Share this article
published Published on Dec 28, 2022   modified Modified on Dec 28, 2022

-The Telegraph

Centre’s vaccine policy advisers earlier this week approved release of intranasal vaccine into the private market

New Delhi: Indian vaccine maker Bharat Biotech announced on Tuesday that its intranasal Covid-19 vaccine, approved by the Centre as a booster dose, would be available at private hospitals for Rs 800 plus additional taxes and service charges per dose.

People 18 years or older who have taken two doses of Covaxin, Covishield or any other Covid-19 vaccine will be eligible for the intranasal vaccine, iNCOVACC, which will serve as a booster dose to enhance immunity against the coronavirus.

Bharat Biotech said iNCOVACC would be priced at Rs 800 for the private market and at Rs 325 for the Centre or state governments if they wish to procure it.

The Centre’s vaccine policy advisers had earlier this week approved the release of the intranasal vaccine into the private market. Eligible people can register for the vaccine through Co-WIN, the government’s digital platform for Covid-19 vaccination.  

Scientists say the most promising aspect of the intranasal vaccine is its potential to generate the so-called sterilising immunity, that is, to stop the virus from replicating in the body.

Animal studies with the intranasal vaccine, designed by scientists at Washington University, St Louis, in the US, had demonstrated this potential. In contrast, the current Covid-19 vaccines protect people from severe disease but are not as effective in preventing infections from new coronavirus variants.

Please click here to read more. 


The Telegraph, 28 December, 2022, https://www.telegraphindia.com/india/nasal-vaccine-priced-at-rs-800-before-taxes/cid/1906284


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close